LEO Pharma Announces U.S. Food and Drug Administration Fast Track Designation for delgocitinib Cream for the Treatment of Adults With Moderate-to-severe Chronic Hand Eczema
The purpose of the Fast Track process is to get important potential new drugs to patients earlier1 BALLERUP, Denmark &...






